Sana Biotechnology, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Sana Biotechnology, Inc. (SANA) had Convertible Preferred Stock, Shares Issued upon Conversion of 134.10 million shares as of 2021-02-28, per its 10-Q filed 2021-11-08.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2021-11-08
- 2021-02-28: Convertible Preferred Stock, Shares Issued upon Conversion 134.10M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2021-02-28 | 134.10M shares 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |